AAIPharma / Cambridge Major Laboratories to Invest $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO

Facebooktwitterlinkedinmail

AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, announced this week the planned investment of at least $10.7 Million to relocate its St. Louis, MO analytical testing facility to the Cortex Innovation Center.

The new facility is a response to increased customer demand and the growing trend of analytical testing outsourcing within the pharmaceutical and biotechnology industries. It will house state-of-the-art equipment in addition to its existing service offerings, and will provide new testing capabilities to meet industry and changing regulatory requirements, such as glass and plastic containers testing for pharmaceutical use, elemental impurities, disinfectant qualification and efficacy studies.

AAIPharma will occupy 37,500-square-feet of the new 4260 Building under construction at 4260 Forest Park Boulevard by a team of St. Louis contractors led by a Tarlton/Interface joint venture. The structural completion and build-out are due to be finished in the fourth quarter of 2016. 4260 is a three-story, 60,000-square-foot structure that also will serve as the home TechShop St. Louis. Cannon Design is the building architect.

Stability chambers at the new facility will be operational prior to AAIPharma moving in so as not to interrupt any studies. Transfer of stability samples to the new facility will occur using temperature controlled equipment and will be monitored to ensure no deviations from specified conditions.

“We are thrilled to welcome AAIPharma / Cambridge Major Labs to our dynamic innovation community,” said Dennis Lower, president of Cortex. “While our recent growth has come from software technology companies like Uber and Square joining Cortes, adding a progressive leader in the bioscience space builds on another one of our core strengths.”

AAI/CML provides innovative analytical testing solutions for manufacturers’ new drug entities, generic drugs, animal health products, medicated consumer health products, chemicals and biopharmaceuticals. Its analytical testing business is comprised of three centers of excellence in St. Louis, MO; Wilmington, NC; andEdison, NJ to serve its regional, national and global customers.

Its current St. Louis, MO facility employs approximately 80 full time staff and specializes in chemical and microbiological analytical testing including raw material testing, drug product release, stability, and environmental monitoring for both sterile and non-sterile drugs.

Cortex, founded in 2002, is home to more than 200 software, consumer product and bioscience technology firms, ranging from mature enterprises such as DuPont, Boeing, AB Mauri, Square, Stereotaxis, the Cambridge Innovation Center (CIC) and Washington University among others, to promising early-stage startups like Aisle411, CoFactor Genomics, and Pushup Social.

Facebooktwitterlinkedinmail

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.